Synthesis of ꢀ-Hydroxy-R-Amino Acids
in the literature.7 Lithium chloride (383 mg, 9 mmol, 6 equiv) was
added to a dry 50 mL long-neck flask under argon. Diisopropy-
lamine (0.234 mL, 1.65 mmol, 1.1 equiv) was added to dry THF
(8 mL) in a long-neck flask. After the solution was cooled to -30
°C, n-BuLi (2.8 M, 0.589 mL, 1.65 mmol, 1.1 equiv) was added
dropwise. The reaction mixture was stirred at -30 °C for 30 min.
Tricyclic iminolactone (310 mg, 1.5 mmol) in dry THF (10 mL)
was added dropwise over a period of 10 min into the above freshly
prepared LDA solution at -30 °C, and then the reaction mixture
was subsequently cooled to -78 °C and stirring was continued for
30 min followed by the addition of the solution of aldehyde (1.8
mmol) in dry THF (10 mL) over a period of 10 min. The well-
stirred reaction was kept at -78 °C for another 1-12 h (after TLC
analysis showed the reaction was complete). Saturated NH4Cl (1
mL) solution was added to the mixture to quench the reaction. The
reaction was warmed up to rt; the solvent was removed under
reduced pressure, and the residue was diluted with water and
extracted with ethyl acetate (3 × 15 mL). The combined organic
phase was washed with water and brine, dried (MgSO4), and
concentrated to give the crude product. The crude product was
purified by column chromatography to yield desired compounds.
(1S,2R,5S,8R,1′S)-5-(1′-Hydroxyethyl)-1,11,11-trimethyl-3-
oxa-6-azatricyclo[6.2.1.02,7]undec-6-en-4-one (2a′): White solid
(320 mg, 85%); [R]20D +52 (c 1.61, CHCl3); mp 139-141 °C; IR
(KBr) 3354 (s), 2990 (m), 1745 (s), 1702 (s) cm-1; 1H NMR (400
MHz, CDCl3) δ 4.78 (s, 1H), 4.43 (d, J ) 4.4 Hz, 1H), 4.18-4.17
(m, 1H), 2.20 (d, J ) 4.8 Hz, 1H), 2.10-2.02 (m, 2H), 1.81-1.74
(m, 1H), 1.66-1.59 (m, 1H), 1.46 (d, J ) 6.8 Hz, 3H), 1.41-1.35
(m, 2H), 1.07 (s, 3H), 0.97 (s, 3H), 0.81 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 182.7, 169.8, 80.1, 69.4, 68.2, 52.9, 48.4, 47.7,
29.3, 25.9, 21.8, 20.1, 19.5, 10.1; HRMS (ESI) calcd for C14H22NO3
[M + H]+ 252.1597, found 252.1594.
General Procedure for Hydrolysis of Aldol Products: The
aldol product (1.2 mmol) was dissolved in 6 N HCl (3 mL) in a
sealed tube with a Teflon screw cap and heated at 80 °C for 3 h.
After cooling to rt, water (5 mL) was added and the mixture was
extracted with diethyl ether (3 × 5 mL). The chiral auxiliary 6 or
7 was recovered when the ether layer was concentrated. The
aqueous layer was evaporated under reduced pressure, and the
residue was dissolved in EtOH (5 mL). Propylene oxide (3 mL)
was then added and stirred at rt for 30 min during which time white
solids precipitated. The precipitate was collected by filtration,
washed successively with cold EtOH (2 × 2 mL) and Et2O (1 × 4
mL), and air-dried to give the desired free ꢀ-hydroxy-R-amino acids.
(2S,3S)-2-Amino-3-hydroxybutanoic Acid (4a): White solid (97
mg, 77%); [R]20D +8 (c 1.1, H2O); mp 264-266 °C; 1H NMR (400
MHz, D2O) δ 4.37 (dd, J ) 6.4, 4 Hz, 1H), 3.84 (d, J ) 4 Hz,
1H), 1.20 (d, J ) 6.4 Hz, 3H); 13C NMR (100 MHz, D2O) δ 171.8,
65.3, 59.6, 16.1.
(2R,3R)-3-Hydroxyleucine (5c): White solid (148 mg, 84%);
1
[R]20 -20 (c 1.26, H2O); mp 187 °C (dec); H NMR (400 MHz,
D
D2O) δ 3.92 (d, J ) 3.2 Hz, 1H), 3.53 (dd, J ) 9.2, 3.2 Hz, 1H),
1.94 (m, 1H), 0.98 (m, 6H); 13C NMR (100 MHz, D2O) δ 171.7,
76.1, 57.1, 30.2, 18.5.
Methyl (4R,5S)-5-Isopropyl-2-phenyl-4,5-dihydrooxazole-4-
carboxylate 9: A solution of amide 8 (398 mg, 1.5 mmol) in THF
(15 mL) was cooled to 0 °C. Thionyl chloride (0.16 mL, 2.25 mmol)
was added to the solution at 0 °C. The reaction mixture was warmed
gradually to 25 °C. After stirring 12 h, the reaction mixture was
heated to 60 °C for 1.5 h. Then the reaction mixture was cooled to
0 °C and quenched with saturated NaHCO3 (15 mL). The aqueous
phase was extracted with ethyl acetate (3 × 15 mL). The combined
organic phase was washed with H2O (10 mL) and brine (10 mL),
dried over Na2SO4, filtered, and concentrated. Flash chromatography
(8:1 petrol ether/EtOAc) afforded 9 (330 mg, 89%) as light yellow
oil: [R]20D -113 (c 0.04, CHCl3); IR υmax (film) 2922, 1741, 1646,
1449, 1385; 1H NMR (400 MHz, CDCl3) δ 1.00 (d, J ) 6.4 Hz,3H),
1.03 (d, J ) 6.4 Hz, 3H), 1.94-1.99 (m, 1H), 3.81 (s, 3H), 4.57
(d, J ) 7.2 Hz, 1H), 4.68 (apparent t, J ) 6.8 Hz, 1H), 7.40-7.43
(m, 2H), 7.48-7.52 (m, 1H), 7.98-8.00 (m, 2H); 13C NMR (100
MHz, CDCl3) δ 17.2, 17.4, 32.4, 52.6, 71.3, 87.2, 127.2, 128.3,
128.5, 131.7, 165.7, 172.0; HRMS (ESI) calcd for C14H18NO3 [M
+ H]+ 248.1281, found 247.1283.
(1S,2R,5S,8R,1′R)-5-(1′-Hydroxy-o-fluorobenzyl)-8,11,11-tri-
methyl-3-oxa-6-azatricyclo [6.2.1.02,7]undec-6-en-4-one (2f):
White solid (372 mg, 75%); [R]20 -33 (c 1.24, CHCl3); mp
D
138-140 °C; IR (KBr) 3194 (b), 2990 (m), 1740 (s), 1690 (s) cm-1
;
1H NMR (400 MHz, CDCl3) δ 7.47-7.43 (m, 1H), 7.33-7.26 (m,
1H), 7.19-7.15 (m, 1H), 7.05-7.00 (m, 1H), 5.63 (d, J ) 4 Hz,
1H), 4.82 (d, J ) 4.4 Hz, 1H), 4.30 (s, 1H), 3.06 (s, 1H), 2.13 (d,
J ) 4.4 Hz, 1H), 2.04-1.97 (m, 1H), 1.78-1.71 (m, 1H),
1.62-1.55 (m, 1H), 1.27-1.21 (m, 1H), 1.00 (s, 3H), 0.93 (s, 3H),
0.76 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 183.5, 170.3, 129.9,
128.1, 127.0, 124.4, 115.4, 115.2, 79.8, 69.4, 66.9, 53.1, 48.2, 47.7,
29.3, 26.0, 20.1, 19.5, 10.1; HRMS (ESI) calcd for C19H23FNO3
[M + H]+ 332.1656, found 332.1660.
Methyl (4R,5R)-5-Isopropyl-2-phenyl-4,5-dihydrooxazole-4-
carboxylate 13: Following the procedure described for 9, the only
change was (2R,3R)-3-hydroxyleucine 5c into (2S,3S)-3-hydroxyleu-
cine 4c: Colorless oil; [R]20 + 113 (c 0.04, CHCl3); IR υmax (film)
D
1
2923, 1733, 1636, 1439, 1383; H NMR (400 MHz, CDCl3) δ 0.98
(1R,2S,5R,8S,1′R)-5-(1′-Hydroxyethyl)-1,11,11-trimethyl-3-
oxa-6-azatricyclo[6.2.1.02,7]undec-6-en-4-one (3a′): Oil (237 mg,
(d, J ) 6.8 Hz, 3H), 1.02 (d, J ) 6.8 Hz, 3H), 1.92-1.97 (m, 1H),
3.79 (s, 3H), 4.56 (d, J ) 6.8 Hz, 1H), 4.66 (apparent t, J ) 6.8 Hz,
1H), 7.38-7.41 (m, 2H), 7.46-7.50 (m, 1H), 7.97-7.99 (m, 2H);
13C NMR (100 MHz, CDCl3) δ 17.2, 17.3, 32.3, 52.5, 71.2, 87.1, 127.1,
128.2, 128.5, 131.7, 165.7, 172.0; HRMS (ESI) calcd for C14H18NO3
[M + H]+ 248.1281, found 247.1286.
1
63%); IR (KBr) 3385 (s), 2964 (m), 1743 (s), 1704 (s) cm-1; H
NMR (400 MHz, CDCl3) δ 4.60 (s, 1H), 4.38 (d, J ) 4.4 Hz, 1H),
4.16 (m, 1H), 2.43 (d, J ) 4.4 Hz, 1H), 2.05-1.98 (m, 1H),
1.92-1.87 (m, 1H), 1.63-1.57 (m, 1H), 1.45 (d, J ) 6.4 Hz, 3H),
1.42-1.36 (m, 1H), 1.05 (s, 3H), 0.97 (s, 3H), 0.85 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ 181.2, 169.5, 82.0, 69.2, 68.0, 53.9,
49.5, 48.2, 34.5, 21.8, 21.4, 20.0, 19.3, 9.7; HRMS (ESI) calcd for
C14H22NO3 [M + H]+ 252.1594, found 252.1588.
Acknowledgment. We are grateful for the financial support
of the National Natural Science Foundation of China (NSFC,
20572039, 20772051), the Program for NCET-05-0880, and the
Doctoral Funds from Chinese Ministry of Education of P.R.
China. We also thank Professor T.-J. Lu for his support.
(1R,2S,5R,8S,1′S)-5-(1′-Hydroxybenzyl)-1,11,11-trimethyl-3-
oxa-6-azatricyclo[6.2.1.02,7]undec-6-en-4-one (3f): White solid
(389 mg, 83%); [R]20D +93 (c 2.52, CH2Cl2); mp 152-153 °C; IR
1
(KBr) 3245 (s), 2960 (s), 1744 (s), 1697 (s) cm-1; H NMR (400
Supporting Information Available: General methods for the
synthesis of racemic ꢀ-hydroxy-R-amino acids, spectra data for
compounds 2d′, 2e′, 2g, 2h, 3a, 3d′, 3e′, 3h, 3i, 4e-4g, 5e-5h,
MHz, CDCl3) δ 7.34-7.32 (m, 3H), 7.28-7.26 (m, 2H), 5.23 (t,
J ) 4.4 Hz, 1H), 4.70 (d, J ) 3.6 Hz, 1H), 3.59 (s, 1H), 3.40 (d,
J ) 4.8 Hz, 1H), 2.32 (d, J ) 4.4 Hz, 1H), 1.96-1.88 (m, 1H),
1.80-1.72 (m, 1H), 151-1.45 (m, 1H), 1.12-1.03 (m, 1H), 0.94
(s, 3H), 0.89 (s, 3H), 0.75 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
181.8, 170.7, 139.8, 128.42, 128.40, 126.3, 81.7, 75.1, 67.1, 53.9,
49.1, 48.0, 34.5, 21.3, 19.8, 19.1, 9.5; HRMS (ESI) calcd for
C19H24NO3 [M + H]+ 314.1751, found 314.1759.
1
and 11-13, as well as copies of H and 13C NMR spectra and
HPLC results. This material is available free of charge via the
JO8023973
J. Org. Chem. Vol. 74, No. 4, 2009 1631